Suven Pharmaceuticals Limited (SUVENPHAR.NS)
INR 1222.2
(-1.95%)
INR 1222.2
(-1.95%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 2.03 Billion INR | -11.77% |
| 2022 | 2.3 Billion INR | -23.76% |
| 2021 | 3.02 Billion INR | 2.98% |
| 2020 | 2.93 Billion INR | -10.48% |
| 2019 | 3.28 Billion INR | 70.21% |
| 2018 | 1.92 Billion INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | -20.5 Billion INR | -1108.08% |
| 2023 Q3 | 765 Million INR | -58.51% |
| 2023 Q2 | 1.84 Billion INR | 0.0% |
| 2023 Q4 | 2.03 Billion INR | 165.91% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 2.03 Billion INR | -11.77% |
| 2022 Q2 | 3.02 Billion INR | 0.0% |
| 2022 FY | 2.3 Billion INR | -23.76% |
| 2022 Q4 | 2.3 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 FY | 3.02 Billion INR | 2.98% |
| 2021 Q4 | 3.02 Billion INR | 0.0% |
| 2021 Q2 | 3.05 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 2.93 Billion INR | -10.48% |
| 2020 Q4 | 2.93 Billion INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 3.08 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 FY | 3.28 Billion INR | 70.21% |
| 2019 Q4 | 3.28 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 FY | 1.92 Billion INR | 0.0% |
| 2018 Q4 | 1.92 Billion INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Sigachi Industries Limited | 2.53 Billion INR | 19.636% |
| Ind-Swift Limited | 13.45 Billion INR | 84.879% |
| Bajaj HealthCare Limited | 4.86 Billion INR | 58.209% |
| Sakar Healthcare Limited | 1.26 Billion INR | -61.028% |
| Aurobindo Pharma Limited | 152.2 Billion INR | 98.664% |
| Innova Captab Limited | 4.89 Billion INR | 58.484% |
| Divi's Laboratories Limited | 18.99 Billion INR | 89.288% |
| AstraZeneca Pharma India Limited | 3.66 Billion INR | 44.437% |
| Morepen Laboratories Limited | 4.45 Billion INR | 54.387% |
| Mankind Pharma Limited | 23.87 Billion INR | 91.48% |
| Sequent Scientific Limited | 8.27 Billion INR | 75.415% |
| Wanbury Limited | 3.15 Billion INR | 35.534% |
| Laurus Labs Limited | 42.71 Billion INR | 95.238% |
| Nectar Lifesciences Limited | 11.21 Billion INR | 81.867% |
| Glenmark Life Sciences Limited | 5.18 Billion INR | 60.736% |
| Alembic Limited | 1.43 Billion INR | -42.045% |
| Hikal Limited | 12.99 Billion INR | 84.346% |
| Alembic Pharmaceuticals Limited | 16.27 Billion INR | 87.5% |
| Neuland Laboratories Limited | 5.49 Billion INR | 63.004% |
| J. B. Chemicals & Pharmaceuticals Limited | 10.7 Billion INR | 81.003% |
| Glenmark Pharmaceuticals Limited | 65.11 Billion INR | 96.876% |
| IOL Chemicals and Pharmaceuticals Limited | 6.32 Billion INR | 67.858% |
| Themis Medicare Limited | 1.88 Billion INR | -7.773% |
| RPG Life Sciences Limited | 1.38 Billion INR | -47.387% |
| Zydus Lifesciences Limited | 71.79 Billion INR | 97.166% |
| Lupin Limited | 96.23 Billion INR | 97.886% |
| Amrutanjan Health Care Limited | 783.82 Million INR | -159.526% |
| Wockhardt Limited | 39.87 Billion INR | 94.898% |
| Vaishali Pharma Limited | 371.16 Million INR | -448.069% |
| Aarti Pharmalabs Limited | 8.25 Billion INR | 75.345% |
| Jagsonpal Pharmaceuticals Limited | 296.76 Million INR | -585.48% |
| Jubilant Pharmova Limited | 61.27 Billion INR | 96.68% |
| FDC Limited | 3.7 Billion INR | 45.157% |
| Dr. Reddy's Laboratories Limited | 106.96 Billion INR | 98.098% |
| Kilitch Drugs (India) Limited | 643.88 Million INR | -215.931% |
| Eris Lifesciences Limited | 38.26 Billion INR | 94.684% |
| Venus Remedies Limited | 1.39 Billion INR | -46.053% |
| ZIM Laboratories Limited | 2.08 Billion INR | 2.236% |
| Bliss GVS Pharma Limited | 2.1 Billion INR | 3.539% |
| Par Drugs and Chemicals Limited | 159.79 Million INR | -1173.056% |
| Caplin Point Laboratories Limited | 3.5 Billion INR | 41.972% |
| Shilpa Medicare Limited | 12.93 Billion INR | 84.27% |
| Albert David Limited | 1.15 Billion INR | -76.873% |
| Ajanta Pharma Limited | 10.71 Billion INR | 81.007% |
| Hester Biosciences Limited | 3.59 Billion INR | 43.411% |
| Solara Active Pharma Sciences Limited | 14.09 Billion INR | 85.564% |
| Gufic Biosciences Limited | 5.59 Billion INR | 63.673% |
| Windlas Biotech Limited | 1.76 Billion INR | -15.404% |
| Procter & Gamble Health Limited | 2.56 Billion INR | 20.575% |
| Aarey Drugs & Pharmaceuticals Limited | 1.72 Billion INR | -18.119% |
| Mangalam Drugs & Organics Limited | 1.97 Billion INR | -2.931% |
| Granules India Limited | 22.95 Billion INR | 91.138% |
| Aarti Drugs Limited | 11.5 Billion INR | 82.317% |
| Bal Pharma Limited | 2.51 Billion INR | 18.996% |
| Alkem Laboratories Limited | 48.6 Billion INR | 95.815% |
| Sun Pharmaceutical Industries Limited | 183.56 Billion INR | 98.892% |
| Lincoln Pharmaceuticals Limited | 1.07 Billion INR | -89.311% |
| Medicamen Biotech Limited | 940.36 Million INR | -116.323% |
| Unichem Laboratories Limited | 8.06 Billion INR | 74.79% |
| Bafna Pharmaceuticals Limited | 652.27 Million INR | -211.865% |
| Biofil Chemicals and Pharmaceuticals Limited | 288.79 Million INR | -604.375% |
| Valiant Laboratories Limited | 1.05 Billion INR | -92.224% |
| Orchid Pharma Limited | 3.84 Billion INR | 47.081% |
| Medico Remedies Limited | 438.24 Million INR | -364.177% |
| Ind-Swift Laboratories Limited | 2.28 Billion INR | 11.148% |
| Ipca Laboratories Limited | 33.74 Billion INR | 93.971% |
| Brooks Laboratories Limited | 248.6 Million INR | -718.271% |
| Syncom Formulations (India) Limited | 1.16 Billion INR | -74.58% |
| Piramal Enterprises Limited | 560.47 Billion INR | 99.637% |
| Torrent Pharmaceuticals Limited | 82.05 Billion INR | 97.521% |
| NATCO Pharma Limited | 10.53 Billion INR | 80.685% |
| Suven Life Sciences Limited | 148.62 Million INR | -1268.736% |
| Krebs Biochemicals & Industries Limited | 2.97 Billion INR | 31.598% |
| Strides Pharma Science Limited | 37.68 Billion INR | 94.601% |
| Indoco Remedies Limited | 10.34 Billion INR | 80.331% |
| Alpa Laboratories Limited | 307.12 Million INR | -562.352% |
| Lasa Supergenerics Limited | 541.92 Million INR | -275.371% |
| Sun Pharma Advanced Research Company Limited | 3.89 Billion INR | 47.745% |